Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
AN ›
ANQLAR
Trademark search for:
ANQLAR
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-03-02 — Application filed
2021-03-05 — Application filed
2021-06-01 — Application filed
2021-09-23 — Assigned to examiner
2021-09-29 — Approved for pub - principal register
2021-10-13 — Notification of notice of publication e-mailed
2021-11-02 — Published for opposition
2021-11-02 — Official gazette publication confirmation e-mailed
2021-12-28 — Noa e-mailed - sou required from applicant
2022-05-25 — Sou teas extension received
2022-05-25 — Sou extension 1 filed
2022-05-25 — Sou extension 1 granted
2022-05-27 — Notice of approval of extension request e-mailed
2022-12-02 — Sou teas extension received
2022-12-02 — Sou extension 2 filed
2022-12-02 — Sou extension 2 granted
2022-12-06 — Notice of approval of extension request e-mailed
2023-06-28 — Sou extension 3 filed
2023-07-31 — Application abandoned
2023-07-31 — Application abandoned
2023-09-05 — Teas petition to revive received
2023-09-05 — Petition to revive-granted
2023-09-05 — Sou extension received with teas petition
2023-09-05 — Notice of revival - e-mailed
2023-10-02 — Case assigned to intent to use paralegal
2023-10-02 — Sou extension 3 granted
2023-10-03 — Notice of approval of extension request e-mailed
2023-12-28 — Sou extension 4 filed
2024-01-29 — Application abandoned
2024-01-29 — Application abandoned
2024-01-30 — Notice of revival - e-mailed
2024-01-30 — Teas petition to revive received
2024-01-30 — Petition to revive-granted
2024-01-30 — Sou extension received with teas petition
2024-02-22 — Sou extension 4 granted
2024-02-23 — Notice of approval of extension request e-mailed
2024-06-28 — Sou teas extension received
2024-06-28 — Notice of approval of extension request e-mailed
2024-06-28 — Sou extension 5 granted
2024-06-28 — Sou extension 5 filed
2025-10-07 — Application abandoned
2025-10-07 — Application abandoned
2025-10-07 — Final status recorded
Owner Information
Virpax Pharmaceuticals Inc.
Virpax Pharmaceuticals Inc.
Correspondent
G Kenneth Smith
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
